Kyverna Therapeutics, Inc. (KYTX) Q3 2024 Earnings
KYTX·Reported November 13, 2024·Before market open
Diluted EPS came in at $-0.80, missed the $-0.77 consensus by $0.03.
Diluted EPS
$-0.80missed by $0.03
Consensus: $-0.77
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Kyverna Therapeutics, Inc.'s Q3 2024 earnings report.
Kyverna Therapeutics, Inc. (KYTX) reported Q3 2024 earnings on November 13, 2024 before market open.
Kyverna Therapeutics, Inc. reported diluted EPS of $-0.80 for Q3 2024.
EPS missed the consensus estimate of $-0.77 by $0.03.
You can read the 10-Q periodic report (0000950170-24-126366) directly on SEC EDGAR. The filing index links above go to sec.gov.